Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of varicella vaccine and hepatitis A vaccine refers to the co-administration of two separate vaccines, each targeting a different viral infection. The varicella vaccine is a live attenuated vaccine that induces immunity against the varicella-zoster virus (VZV), which causes chickenpox. It works by stimulating the immune system to produce antibodies against VZV, providing protection from future infection[1][6][8]. The hepatitis A vaccine is an inactivated (killed) virus vaccine that protects against hepatitis A virus (HAV) infection by inducing an immune response and antibody production specific to HAV[7]. Both vaccines are recommended for routine immunization in children starting at 12 months of age, with two doses required for long-term protection[3][7]. These vaccines may be administered simultaneously but as separate injections; there is no single licensed product combining both antigens into one formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on varicella vaccine + hepatitis A vaccine.